Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

Table of Contents

(6)
Allergan, Inc. is publicly-traded corporation, with its common stock traded on the New York Stock Exchange. The address of Allergan, Inc. is 2525 Dupont Drive, Irvine, California 92612.

(7)
Includes options to purchase 4,375,406 shares of common stock that may be exercised within 60 days of July 31, 2014.

(8)
Includes options to purchase 2,680,039 shares of common stock that may be exercised within 60 days of July 31, 2014.

(9)
Includes options to purchase 4,320,780 shares of common stock that may be exercised within 60 days of July 31, 2014.

(10)
Consists of the shares described in note (4) above. Dr. Barrett is a partner of Atlas Venture, and as such Dr. Barrett may be deemed to share voting and dispositive power with respect to all shares held by such entity. Dr. Barrett disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. Dr. Barrett's business address is 25 First Street, Suite 303, Cambridge, Massachusetts 02141.

(11)
Includes (i) 253,085 shares held directly by G&H Partners; and (ii) options to purchase 334,093 shares of common stock that may be exercised within 60 days of July 31, 2014. Mr. Gunderson is a general partner of G&H Partners, and as such he may be deemed to share voting and dispositive power with respect to the shares held by G&H Partners. Mr. Gunderson disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

(12)
Includes options to purchase 1,991,180 shares of common stock that may be exercised within 60 days of July 31, 2014.

(13)
Mr. Newhall is a retired co-founder of NEA. Mr. Newhall does not have voting or dispositive power with regard to any of the shares directly held by entities affiliated with NEA referenced in note (2) above.

(14)
Consists of the shares described in note (3) above. Dr. Roberts is a general partner of Venrock Associates and disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest in them.

(15)
Includes options to purchase 11,021,459 shares of common stock that may be exercised within 60 days of July 31, 2014.

145